Wong Benjamin C, Gillman Nicole C, Oehninger Sergio, Gibbons William E, Stadtmauer Laurel A
Department of Obstetrics and Gynecology, The Howard and Georgeanna Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA.
Am J Obstet Gynecol. 2004 Aug;191(2):597-606; discussion 606-7. doi: 10.1016/j.ajog.2004.05.079.
The purpose of this study was to investigate the effect of endometriomas on clinical pregnancy rates of in vitro fertilization-embryo transfer.
Infertile patients with endometriosis who underwent in vitro fertilization-embryo transfer were divided into group 1 patients who had a history of ovarian endometriomas and group 2 patients who did not. The patients in group 1 were further divided into group 1A who had their endometriomas removed by laparoscopic ovarian cystectomy before the start of in vitro fertilization-embryo transfer and group 1B who underwent in vitro fertilization-embryo transfer with the presence of endometriomas. The clinical pregnancy rates of these groups were compared.
Clinical pregnancy rates per transfer were similar in group 1 and group 2 (40% vs 47%; P =.38) and similar in patients in group 1A and group 1B (47% vs 34%; P =.28), although the direction was toward improved pregnancy rates in the groups of patients without endometriomas present at the time of in vitro fertilization stimulation. When patients >39 years of age were excluded, the overall pregnancy rate was higher in those patients who had no current endometriomas than in those patients who had endometriomas present at the time of stimulation (65% vs 39%; P =.05). For patients with unilateral endometriomas, similar numbers of mature oocytes were aspirated between the affected and unaffected ovaries.
Although the history of endometriomas does not appear to affect in vitro fertilization-embryo transfer outcomes adversely, there may be a benefit in the removal of endometriomas before in vitro fertilization.
本研究旨在探讨卵巢子宫内膜异位囊肿对体外受精-胚胎移植临床妊娠率的影响。
将接受体外受精-胚胎移植的子宫内膜异位症不孕患者分为两组,1组为有卵巢子宫内膜异位囊肿病史的患者,2组为无该病史的患者。1组患者进一步分为1A组和1B组,1A组在体外受精-胚胎移植开始前通过腹腔镜卵巢囊肿切除术切除子宫内膜异位囊肿,1B组在存在子宫内膜异位囊肿的情况下接受体外受精-胚胎移植。比较这些组的临床妊娠率。
1组和2组每次移植的临床妊娠率相似(40%对47%;P = 0.38),1A组和1B组患者的临床妊娠率也相似(47%对34%;P = 0.28),尽管在体外受精刺激时不存在子宫内膜异位囊肿的患者组中妊娠率有提高的趋势。排除年龄>39岁的患者后,当前无子宫内膜异位囊肿的患者的总体妊娠率高于刺激时存在子宫内膜异位囊肿的患者(65%对39%;P = 0.05)。对于单侧子宫内膜异位囊肿患者,患侧和未患侧卵巢吸出的成熟卵母细胞数量相似。
虽然子宫内膜异位囊肿病史似乎不会对体外受精-胚胎移植结局产生不利影响,但在体外受精前切除子宫内膜异位囊肿可能有益。